The first Sorrento Therapeutics trade was made in Q4 2017.
Since then Joel Greenblatt bought shares two more times and sold shares on four occasions. The investor completely sold their stake between Q3 2020 and Q4 2020.
Avg closing price
Price range
Sold -19.9 Thousand shares
Q4 2020
Avg closing price
$8.03
Price range
$5.76
-
$11.95
Sold 39.0% shares (-12.8 Thousand shares)
Q3 2020
Avg closing price
$9.15
Price range
$6.17
-
$18.82
New holding (+32.7 Thousand shares)
Q2 2020
Avg closing price
$3.83
Price range
$1.73
-
$6.76
Sold -131 Thousand shares
Q3 2018
Avg closing price
$5.54
Price range
$4.22
-
$7.50
Sold 21.0% shares (-34.7 Thousand shares)
Q2 2018
Avg closing price
$6.80
Price range
$4.75
-
$8.00
Increased shares by 285.9% (+123 Thousand shares)
Q1 2018